Middleton & Co’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.27M Buy
20,858
+1,688
+9% +$763K 0.94% 36
2025
Q4
$9M Sell
19,170
-2,542
-12% -$1.13M 0.96% 36
2025
Q3
$10.7M Buy
21,712
+2,089
+11% +$1.18M 1.16% 26
2025
Q2
$10.1M Buy
19,623
+429
+2% +$200K 1.13% 29
2025
Q1
$8.23M Sell
19,194
-243
-1% -$118K 0.96% 38
2024
Q4
$9.43M Buy
19,437
+2,042
+12% +$1.07M 1.04% 33
2024
Q3
$8.81M Buy
17,395
+681
+4% +$365K 0.97% 37
2024
Q2
$9.95M Buy
16,714
+450
+3% +$254K 1.16% 31
2024
Q1
$9.29M Buy
16,264
+1,135
+8% +$625K 1.07% 33
2023
Q4
$7.79M Buy
15,129
+2,515
+20% +$1.29M 0.97% 35
2023
Q3
$5.79M Buy
12,614
+1,281
+11% +$573K 0.8% 44
2023
Q2
$4.93M Buy
+11,333
New +$4.56M 0.65% 48

Other funds holding SNPS

Middleton & Co's SNPS Position: Q1 2026 in Review

Middleton & Co increased its Synopsys (SNPS) stake by 8.8% in Q1 2026, buying an estimated $763K and bringing the position to 20,858 shares worth $8.27M. The position accounts for 0.94% of the portfolio, ranked #36.

Middleton & Co first reported a position in SNPS in Q2 2023 and has held it in 12 quarters since. The position peaked at $10.7M in Q3 2025. 1,391 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • Middleton & Co held 20,858 shares of Synopsys worth $8.27M as of Q1 2026.
  • Middleton & Co bought 1,688 Synopsys shares in Q1 2026, an estimated $763K.
  • Synopsys made up 0.94% of Middleton & Co's portfolio in Q1 2026, its #36 holding.
  • Middleton & Co first reported a position in Synopsys in Q2 2023 and has held it in 12 quarters since.
  • Middleton & Co's Synopsys position peaked at $10.7M in Q3 2025.
  • 1,391 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on Middleton & Co's 13F filing for Q1 2026, filed 8 May 2026.